BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26638594)

  • 1. Radiofrequency Ablation of Lung Metastasis Not Suitable for Surgery: Experience in Siriraj Hospital.
    Tongdee T; Tantigate P; Tongdee R
    J Med Assoc Thai; 2015 Oct; 98(10):1019-27. PubMed ID: 26638594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
    Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
    Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
    Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
    Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical short-term results of radiofrequency ablation in liver cancers.
    Jiang HC; Liu LX; Piao DX; Xu J; Zheng M; Zhu AL; Qi SY; Zhang WH; Wu LF
    World J Gastroenterol; 2002 Aug; 8(4):624-30. PubMed ID: 12174368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
    Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
    Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
    Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
    Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
    Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.
    Toshimori J; Nouso K; Nakamura S; Wada N; Morimoto Y; Takeuchi Y; Yasunaka T; Kuwaki K; Ohnishi H; Ikeda F; Shiraha H; Takaki A; Yamamoto K
    Acta Med Okayama; 2015; 69(4):219-26. PubMed ID: 26289913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of complication and tumor recurrence after radiofrequency ablation in high-risk location of hepatocellular carcinoma patients.
    Thamtorawat S; Limsuwarn P; Tongdee T; Chaiyasoot W; Siriapisith T
    J Med Assoc Thai; 2014 Jan; 97(1):95-100. PubMed ID: 24701735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma.
    Yan TD; King J; Sjarif A; Glenn D; Steinke K; Al-Kindy A; Morris DL
    Ann Surg Oncol; 2007 May; 14(5):1718-26. PubMed ID: 17285398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.